AVGCX | MBXFX | AVGCX / MBXFX | |
Total Expense Ratio | 2.15 | 3.03 | 71% |
Annual Report Gross Expense Ratio | 2.90 | 3.03 | 96% |
Fund Existence | 19 years | 5 years | - |
Gain YTD | -1.440 | -2.608 | 55% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 77.5M | 8.05B | 1% |
Annual Yield % from dividends | 9.30 | 1.17 | 793% |
Returns for 1 year | -0.22 | -2.00 | 11% |
Returns for 3 years | 10.67 | 4.52 | 236% |
Returns for 5 years | -1.96 | N/A | - |
Returns for 10 years | -8.72 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 22.87 | N/A | N/A |
Saratoga Health & Biotechnology I | |||
AFGPX | 18.11 | N/A | N/A |
Alger International Opportunities B | |||
GSMQX | 18.52 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth Svc | |||
JLCWX | 70.51 | N/A | N/A |
JHancock Fundamental Large Cap Core R6 | |||
WSCRX | 33.77 | N/A | N/A |
Allspring Small Company Growth R6 |